
Biomea Fusion, Inc.
Biomea Fusion, Inc. (BMEA)
WebsitePrice
Market cap
Next catalyst2H 2026icovamenib — planned extended-dosing T1D study · Trial initiationCompany release ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved